Publication

From knemometry to final adult height: Inhaled corticosteroids and their effect on growth in childhood

de Vreede, I., Haarman, E. G., Sprikkelman, A. B. & van Aalderen, W. M., Jun-2013, In : Paediatric respiratory reviews. 14, 2, p. 107-111 5 p.

Research output: Contribution to journalReview articleAcademicpeer-review

APA

de Vreede, I., Haarman, E. G., Sprikkelman, A. B., & van Aalderen, W. M. (2013). From knemometry to final adult height: Inhaled corticosteroids and their effect on growth in childhood. Paediatric respiratory reviews, 14(2), 107-111. https://doi.org/10.1016/j.prrv.2012.05.001

Author

de Vreede, Ilja ; Haarman, Eric G. ; Sprikkelman, Aline B. ; van Aalderen, Wim M. / From knemometry to final adult height : Inhaled corticosteroids and their effect on growth in childhood. In: Paediatric respiratory reviews. 2013 ; Vol. 14, No. 2. pp. 107-111.

Harvard

de Vreede, I, Haarman, EG, Sprikkelman, AB & van Aalderen, WM 2013, 'From knemometry to final adult height: Inhaled corticosteroids and their effect on growth in childhood', Paediatric respiratory reviews, vol. 14, no. 2, pp. 107-111. https://doi.org/10.1016/j.prrv.2012.05.001

Standard

From knemometry to final adult height : Inhaled corticosteroids and their effect on growth in childhood. / de Vreede, Ilja; Haarman, Eric G.; Sprikkelman, Aline B.; van Aalderen, Wim M.

In: Paediatric respiratory reviews, Vol. 14, No. 2, 06.2013, p. 107-111.

Research output: Contribution to journalReview articleAcademicpeer-review

Vancouver

de Vreede I, Haarman EG, Sprikkelman AB, van Aalderen WM. From knemometry to final adult height: Inhaled corticosteroids and their effect on growth in childhood. Paediatric respiratory reviews. 2013 Jun;14(2):107-111. https://doi.org/10.1016/j.prrv.2012.05.001


BibTeX

@article{81770851c8b745d9bc92b22dd4b742e0,
title = "From knemometry to final adult height: Inhaled corticosteroids and their effect on growth in childhood",
abstract = "Growth impairment in children with asthma, as a consequence of inhaled corticosteroids (ICS), is a major issue. Adverse systemic effects of ICS have been reviewed extensively, but no clinically relevant effects are reported if they are used in an appropriate dose as advocated in most guidelines. Growth studies can be divided into knemometry studies, intermediate term studies, and long term studies up to final adult height. These different studies provide different information. Knemometry demonstrates a dose dependent systemic effect, while all intermediate term studies demonstrate growth reduction of approximately one cm after one year of treatment. Most reassuring is that this delay seems to be temporary. The one study with a follow-up to final height shows no differences between the ICS and non-ICS treated children. The studies suggest that the use of ICS with respect to growth is safe if these drugs are used in a low to medium dose. (C) 2012 Elsevier Ltd. All rights reserved.",
keywords = "Inhaled corticosteroids, Asthma, Height, Child, Side-effects, MILD PERSISTENT ASTHMA, LOW-DOSE CICLESONIDE, TO-MODERATE ASTHMA, LONG-TERM SAFETY, LOWER-LEG GROWTH, FLUTICASONE PROPIONATE, BECLOMETHASONE DIPROPIONATE, PRESCHOOL-CHILDREN, CONTROLLED TRIAL, OPEN-LABEL",
author = "{de Vreede}, Ilja and Haarman, {Eric G.} and Sprikkelman, {Aline B.} and {van Aalderen}, {Wim M.}",
year = "2013",
month = jun,
doi = "10.1016/j.prrv.2012.05.001",
language = "English",
volume = "14",
pages = "107--111",
journal = "Paediatric respiratory reviews",
issn = "1526-0542",
publisher = "ELSEVIER SCI LTD",
number = "2",

}

RIS

TY - JOUR

T1 - From knemometry to final adult height

T2 - Inhaled corticosteroids and their effect on growth in childhood

AU - de Vreede, Ilja

AU - Haarman, Eric G.

AU - Sprikkelman, Aline B.

AU - van Aalderen, Wim M.

PY - 2013/6

Y1 - 2013/6

N2 - Growth impairment in children with asthma, as a consequence of inhaled corticosteroids (ICS), is a major issue. Adverse systemic effects of ICS have been reviewed extensively, but no clinically relevant effects are reported if they are used in an appropriate dose as advocated in most guidelines. Growth studies can be divided into knemometry studies, intermediate term studies, and long term studies up to final adult height. These different studies provide different information. Knemometry demonstrates a dose dependent systemic effect, while all intermediate term studies demonstrate growth reduction of approximately one cm after one year of treatment. Most reassuring is that this delay seems to be temporary. The one study with a follow-up to final height shows no differences between the ICS and non-ICS treated children. The studies suggest that the use of ICS with respect to growth is safe if these drugs are used in a low to medium dose. (C) 2012 Elsevier Ltd. All rights reserved.

AB - Growth impairment in children with asthma, as a consequence of inhaled corticosteroids (ICS), is a major issue. Adverse systemic effects of ICS have been reviewed extensively, but no clinically relevant effects are reported if they are used in an appropriate dose as advocated in most guidelines. Growth studies can be divided into knemometry studies, intermediate term studies, and long term studies up to final adult height. These different studies provide different information. Knemometry demonstrates a dose dependent systemic effect, while all intermediate term studies demonstrate growth reduction of approximately one cm after one year of treatment. Most reassuring is that this delay seems to be temporary. The one study with a follow-up to final height shows no differences between the ICS and non-ICS treated children. The studies suggest that the use of ICS with respect to growth is safe if these drugs are used in a low to medium dose. (C) 2012 Elsevier Ltd. All rights reserved.

KW - Inhaled corticosteroids

KW - Asthma

KW - Height

KW - Child

KW - Side-effects

KW - MILD PERSISTENT ASTHMA

KW - LOW-DOSE CICLESONIDE

KW - TO-MODERATE ASTHMA

KW - LONG-TERM SAFETY

KW - LOWER-LEG GROWTH

KW - FLUTICASONE PROPIONATE

KW - BECLOMETHASONE DIPROPIONATE

KW - PRESCHOOL-CHILDREN

KW - CONTROLLED TRIAL

KW - OPEN-LABEL

U2 - 10.1016/j.prrv.2012.05.001

DO - 10.1016/j.prrv.2012.05.001

M3 - Review article

VL - 14

SP - 107

EP - 111

JO - Paediatric respiratory reviews

JF - Paediatric respiratory reviews

SN - 1526-0542

IS - 2

ER -

ID: 71337077